[デキサメタゾン - 創傷治癒障害と高血糖症の危険因子]
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|September 4, 2025
まとめ
術後の吐き気,痛み,入院期間を効果的に軽減します. このステロイド治療は,血糖値が軽微で臨床的に無意味な増加のみで,制御された糖尿病患者にとって安全です.
科学分野:
- 麻酔科
- 薬理学について
- 外科 治療
背景:
- 手術後の吐き気や嘔吐 (PONV) は一般的な合併症です.
- 痛みの管理と入院期間を短くすることは 手術による回復の重要な目標です
- 傷の治癒と血糖値のコントロールは 手術患者のための重要な考慮事項です
研究 の 目的:
- 術後の合併症の軽減におけるデキサメタゾンの単一投与量の有効性を評価する.
- 術後のデキサメタゾンの安全性を評価する.
- 傷の治癒と血糖値に対するデキサメタゾンの影響を決定する.
主な方法:
- 将来の研究デザイン
- 手術中にデキサメタソンを1回投与する.
- 術後の吐き気,痛み,入院期間,傷の治癒,血糖値のモニタリング
主要な成果:
- デキサメタゾンは,手術後の吐き気,痛み,入院期間を大幅に軽減しました.
- 創傷治癒障害のリスク増加は認められなかった.
- 血糖値の微小で臨床的に無意味な上昇を示した.
結論:
- 一回投与された手術前デキサメタゾンは,手術後の結果を管理するための安全で効果的な選択肢です.
- 傷の整体性を損なうことなく 患者の回復を改善します
- デキサメタゾンは,手術を受ける糖尿病患者で,血糖値の注意深いモニタリングで安全に使用できます.
関連する概念動画
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications
684
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
684
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Insulin: Dosing Regimen and Adverse Effects
252
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
252
Adrenal Gland Disorders
1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K


